OraSure wins FDA emergency use nod for new Ebola test
Seeking Alpha News (Wed, 22-Jul 9:29 AM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Wed, 22-Jul 7:21 AM ET)
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
Globe Newswire (Tue, 21-Jul 4:30 PM ET)
Globe Newswire (Thu, 11-Jun 8:00 AM ET)
OraSure Announces First Quarter 2026 Financial Results
Globe Newswire (Wed, 6-May 4:05 PM ET)
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
Globe Newswire (Wed, 22-Apr 4:10 PM ET)
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
Orasure Technologies trades on the NASDAQ stock market under the symbol OSUR.
As of July 22, 2026, OSUR stock price declined to $3.75 with 141,639 million shares trading.
OSUR has a beta of 1.20, meaning it tends to be more sensitive to market movements. OSUR has a correlation of 0.10 to the broad based SPY ETF.
OSUR has a market cap of $258.18 million. This is considered a Small Cap stock.
Last quarter Orasure Technologies reported $28 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $218,080 and missed earnings estimates by -$.07.
In the last 3 years, OSUR traded as high as $8.45 and as low as $2.08.
The top ETF exchange traded funds that OSUR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OSUR has underperformed the market in the last year with a price return of +15.4% while the SPY ETF gained +20.3%. However, in the short term, OSUR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.7% vs +6.6% return in SPY. But in the last 2 weeks, OSUR shares have been beat by the market, returning -13.2% compared to an SPY return of +0.1%.
OSUR support price is $3.70 and resistance is $3.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSUR shares will trade within this expected range on the day.
